BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang YG, Huang PP, Zhang R, Ma BY, Zhou XM, Sun YF. Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma. World J Gastroenterol 2016; 22(1): 326-337 [PMID: 26755879 DOI: 10.3748/wjg.v22.i1.326]
URL: https://www.wjgnet.com/1007-9327/full/v22/i1/326.htm
Number Citing Articles
1
Adrianne L. Jenner, Chae-Ok Yun, Peter S. Kim, Adelle C. F. Coster. Mathematical Modelling of the Interaction Between Cancer Cells and an Oncolytic Virus: Insights into the Effects of Treatment Protocols. Bulletin of Mathematical Biology 2018; 80(6) doi: 10.1007/s11538-018-0424-4
2
Olaniyi Olarewaju, Franziska Held, Pamela Curtis, Cynthia Hess Kenny, Udo Maier, Tadas Panavas, Francois du Plessis. αFAP-specific nanobodies mediate a highly precise retargeting of modified AAV2 capsids thereby enabling specific transduction of tumor tissues. Molecular Therapy - Methods & Clinical Development 2024; 32(4) doi: 10.1016/j.omtm.2024.101378
3
Changhoon Choi, Gyu Sang Yoo, Won Kyung Cho, Hee Chul Park. Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma. World Journal of Gastroenterology 2019; 25(20): 2416-2429 doi: 10.3748/wjg.v25.i20.2416
4
Saeed Ali, Sameer Prakash, Arvind R. Murali. Hepatic Manifestations of Nonhepatotropic Infectious Agents Including Severe Acute Respiratory Syndrome Coronavirus-2, Adenovirus, Herpes Simplex Virus, and Coxiella burnetii. Gastroenterology Clinics of North America 2021; 50(2) doi: 10.1016/j.gtc.2021.02.012
5
Kenya Kamimura, Takeshi Yokoo, Hiroyuki Abe, Shuji Terai. Gene Therapy for Liver Cancers: Current Status from Basic to Clinics. Cancers 2019; 11(12) doi: 10.3390/cancers11121865
6
Bijay Dhungel, Charmaine A. Ramlogan-Steel, Christopher J. Layton, Jason C. Steel. MicroRNA199a-Based Post-transcriptional Detargeting of Gene Vectors for Hepatocellular Carcinoma. Molecular Therapy Nucleic Acids 2018; 13 doi: 10.1016/j.omtn.2018.08.016
7
Payal Deepak, Rajinikanth Siddalingam, Praveen Kumar, Sneha Anand, Sunita Thakur, Balasubramaniam Jagdish, Shweta Jaiswal. Gene based nanocarrier delivery for the treatment of hepatocellular carcinoma. Journal of Drug Delivery Science and Technology 2020; 59 doi: 10.1016/j.jddst.2020.101837
8
M. Aravintha Siva, R. Mahalakshmi, Dipita Bhakta-Guha, Gunjan Guha. Gene therapy for the mitochondrial genome: Purging mutations, pacifying ailments. Mitochondrion 2019; 46 doi: 10.1016/j.mito.2018.06.002
9
Adel Galal El-Shemi, Ahmad Mohammed Ashshi, Youjin Na, Yan Li, Mohammed Basalamah, Faisal Ahmad Al-Allaf, Eonju Oh, Bo-Kyeong Jung, Chae-Ok YUN. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model. Journal of Experimental & Clinical Cancer Research 2016; 35(1) doi: 10.1186/s13046-016-0353-8
10
Adrian Kuzmanović, Cheng Lin, Matthias Bartneck. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2023; 3 doi: 10.1007/16833_2023_129
11
Yonggan Ji, Hongli Fan, Mengmeng Yang, Changcai Bai, Wen Yang, Zhisheng Wang. Synergistic Effect of Baculovirus-Mediated Endostatin and Angiostatin Combined with Gemcitabine in Hepatocellular Carcinoma. Biological and Pharmaceutical Bulletin 2022; 45(3) doi: 10.1248/bpb.b21-00857
12
Patrick L. Mulcrone, Roland W. Herzog, Weidong Xiao. Adding recombinant AAVs to the cancer therapeutics mix. Molecular Therapy - Oncolytics 2022; 27 doi: 10.1016/j.omto.2022.09.009
13
Ali Gawi Ermi, Rabha M. Younis, Kayla Rodriguez, Devanand Sarkar. Gene Therapy Strategies for Hepatocellular Carcinoma (HCC): Current Landscape and Future Directions. Cancers 2025; 17(22) doi: 10.3390/cancers17223608
14
Yuwei Li, Yinan Shen, Ronghua Zhao, Ismael Samudio, William Jia, Xueli Bai, Tingbo Liang. Oncolytic virotherapy in hepato‐bilio‐pancreatic cancer: The key to breaking the log jam?. Cancer Medicine 2020; 9(9) doi: 10.1002/cam4.2949
15
Weiqiang Shen, Shuyuan Chen, Zhongwan Li, Wei Yu. Significant Enhancement of Adeno‐Associated Virus Vector Yield for Gene Therapy Using Multidimensional Optimization Strategies. The FASEB Journal 2025; 39(23) doi: 10.1096/fj.202502611RR
16
A Galal El-Shemi, A Mohammed Ashshi, E Oh, B-K Jung, M Basalamah, A Alsaegh, C-O Yun. Efficacy of combining ING4 and TRAIL genes in cancer-targeting gene virotherapy strategy: first evidence in preclinical hepatocellular carcinoma. Gene Therapy 2018; 25(1) doi: 10.1038/gt.2017.86
17
Kenneth Lundstrom. Latest Trends in Cancer Therapy Applying Viral Vectors. Future Virology 2017; 12(11) doi: 10.2217/fvl-2017-0070
18
Fang Huang, Bin-Rong Wang, Ye-Qing Wu, Fan-Chao Wang, Jian Zhang, Yi-Gang Wang. Oncolytic viruses against cancer stem cells: A promising approach for gastrointestinal cancer. World Journal of Gastroenterology 2016; 22(35): 7999-8009 doi: 10.3748/wjg.v22.i35.7999
19
Huiling Tian, Long Cheng, Yunhui Liang, Hongyuan Lei, Miaomiao Qin, Xinyun Li, Yongshen Ren. MicroRNA therapeutic delivery strategies: A review. Journal of Drug Delivery Science and Technology 2024; 93 doi: 10.1016/j.jddst.2024.105430
20
Saranya Chidambaranathan Reghupaty, Devanand Sarkar. Current Status of Gene Therapy in Hepatocellular Carcinoma. Cancers 2019; 11(9) doi: 10.3390/cancers11091265
21
Adrianne Jenner, Adelle Coster, Peter Kim, Federico Frascoli. Treating Cancerous Cells with Viruses: Insights from Aminimal Model for Oncolytic Virotherapy. Letters in Biomathematics 2018; 5(2) doi: 10.30707/LiB5.2Jenner
22
Fang Huang, Bing-Rong Wang, Yi-Gang Wang. Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(41): 4643-4651 doi: 10.3748/wjg.v24.i41.4643
23
Alisha M. Gruntman, Terence R. Flotte. The rapidly evolving state of gene therapy. The FASEB Journal 2018; 32(4) doi: 10.1096/fj.201700982R
24
Subhajit Pathak, Vijayata Singh, Narendra Kumar, Giridhara R. Jayandharan. Inducible caspase 9-mediated suicide gene therapy using AAV6 vectors in a murine model of breast cancer. Molecular Therapy Methods & Clinical Development 2023; 31 doi: 10.1016/j.omtm.2023.101166
25
Marianna Hösel, Anke Huber, Susanne Bohlen, Julie Lucifora, Giuseppe Ronzitti, Francesco Puzzo, Florence Boisgerault, Ulrich T. Hacker, Wilhelmus J. Kwanten, Nora Klöting, Matthias Blüher, Alexander Gluschko, Michael Schramm, Olaf Utermöhlen, Wilhelm Bloch, Federico Mingozzi, Oleg Krut, Hildegard Büning. Autophagy determines efficiency of liver‐directed gene therapy with adeno‐associated viral vectors. Hepatology 2017; 66(1) doi: 10.1002/hep.29176
26
Xue Yang, Shuangshuang Li, Huiju Wang, Wanyuan Chen, Xiaozhou Mou, Shibing Wang. Expression of coxsackie and adenovirus receptor is correlated with inferior prognosis in liver cancer patients. Oncology Letters 2018;  doi: 10.3892/ol.2018.9868
27
Licheng Zhu, Yu Lei, Jia Huang, Yahang An, Yanqiao Ren, Lei Chen, Huangxuan Zhao, Chuansheng Zheng. Recent advances in oncolytic virus therapy for hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1172292
28
Jian Zhang, Weijie Lai, Qiang Li, Yang Yu, Jin Jin, Wan Guo, Xiumei Zhou, Xinyuan Liu, Yigang Wang. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models. Biochemical and Biophysical Research Communications 2017; 491(2) doi: 10.1016/j.bbrc.2017.07.041
29
Yan Zhao, Qi Deng, Zhipeng Qiu, Ting Guo, Shigui Ruan. Modeling the Interaction of Cytotoxic T-Lymphocytes and Oncolytic Viruses in a Tumor Microenvironment. SIAM Journal on Applied Mathematics 2025; 85(2) doi: 10.1137/23M1613608
30
Taicheng Lu, Zhenzhen Nong, Liying Wei, Mei Wei, Guo Li, Nini Wu, Cheng Liu, Bingling Tang, Qixiao Qin, Xuehua Li, Fayan Meng. Preparation and anti-cancer activity of transferrin/folic acid double-targeted graphene oxide drug delivery system. Journal of Biomaterials Applications 2020; 35(1) doi: 10.1177/0885328220913976
31
Bryan Mckiver, Mohamad Imad Damaj, Devanand Sarkar. Assessment of Current Gene Therapy Practices in Hepatocellular Carcinoma. Gastrointestinal Disorders 2020; 2(4) doi: 10.3390/gidisord2040042
32
Linwen Zhu, Tianwen Li, Yijing Shen, Xiuchong Yu, Bingxiu Xiao, Junming Guo. Using tRNA halves as novel biomarkers for the diagnosis of gastric cancer. Cancer Biomarkers 2019; 25(2) doi: 10.3233/CBM-182184
33
Eesha Chakraborty, Devanand Sarkar. Emerging Therapies for Hepatocellular Carcinoma (HCC). Cancers 2022; 14(11) doi: 10.3390/cancers14112798
34
Wenhua He, Qingxuan Li, Yan Lu, Dingyue Ju, Yu Gu, Kai Zhao, Chuanming Dong. Cancer Treatment Evolution from Traditional Methods to Stem Cells and Gene Therapy. Current Gene Therapy 2022; 22(5) doi: 10.2174/1566523221666211119110755
35
Jialiang Wang, Huan Wei, Yanlin Huang, Dongmei Chen, Guofen Zeng, Yifan Lian, Yuehua Huang. The combination of lonafarnib and sorafenib induces cyclin D1 degradation via ATG3-mediated autophagic flux in hepatocellular carcinoma cells. Aging 2019; 11(15) doi: 10.18632/aging.102165
36
Nusrat Khan, Sridhar Bammidi, Sourav Chattopadhyay, Giridhara R. Jayandharan. Combination Suicide Gene Delivery with an Adeno-Associated Virus Vector Encoding Inducible Caspase-9 and a Chemical Inducer of Dimerization Is Effective in a Xenotransplantation Model of Hepatocellular Carcinoma. Bioconjugate Chemistry 2019; 30(6) doi: 10.1021/acs.bioconjchem.9b00291
37
Jeong Heo, Ja-Der Liang, Chang Won Kim, Hyun Young Woo, I-Lun Shih, Tung-Hung Su, Zhong-Zhe Lin, So Young Yoo, Stanley Chang, Yasuo Urata, Pei-Jer Chen. Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial. Molecular Therapy 2023; 31(7) doi: 10.1016/j.ymthe.2023.04.006
38
Pavel Marichal-Gallardo, Kathleen Börner, Michael M. Pieler, Vera Sonntag-Buck, Martin Obr, David Bejarano, Michael W. Wolff, Hans-Georg Kräusslich, Udo Reichl, Dirk Grimm. Single-Use Capture Purification of Adeno-Associated Viral Gene Transfer Vectors by Membrane-Based Steric Exclusion Chromatography. Human Gene Therapy 2021; 32(17-18) doi: 10.1089/hum.2019.284